5Spada RS, Toscano G, Chiarenaza S, et al. Ischemic stroke and fibrinogen in the elderly[J]. Arch Gemntol Gefiatr Suppl, 2004, 2(9):403-406.
6Sabeti S, Exner M, M lekusch W, et al. Prognostic impact of fibrinogen in carotid atherosclerosis nonspecific indicator of inflam marion or independent predictor of disease progression? [J] Stroke, 2005, 36:1400-1404.
7Wang F, Wang C, Li M , et al. Crystal structure of earthworm fibrinolytic enzyme component A : a novel, glycosylated two-chained trypsin [J]. J Mol Biol, 2005, 348:671-685.
8Fibrinogen Studies Colaboration, Danesh J, Lewington S, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant Meta-analysis [J] . JAM A, 2005, 294:1799-1809.
9Hennerici MG , Kay R , Bogousslavsky J, et al. Intravenous ancrod for acute ischaemic stroke in the European stroke treatment with Ancrod Trial: a randomised controlled trial [J]. Lancet, 2006, 368(9550):1871-1878.
10Cao Y J, Wang YM, Zhang J, et al The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction[J]. J Thromb Thrombolysis, 2009, 27:233-238.
